adagene.com (ADAG) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Adagene (ADAG) faces financial challenges due to a high dependence on external funding and the uncertainty surrounding early-stage research. This chart illustrates the share value in the context of EV/EBITDA as 0.00. Stability is provided by partnerships with industry behemoths, which allow the company to monetize patents without engaging in pricing wars. The business relies on an AI system to create safe antibodies targeted at combating tumors within the immuno-oncology segment.
adagene.com - analytical breakdowns and key metrics (ADAG)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ADAG - Net Profit|Projected Future Earnings Adagene|ADAG - Market Cap to Net Income Ratio|Forward P/E Multiple Adagene Inc.|ADAG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ADAG|ADAG - Operating profit before amortization|Net earnings per share (EPS TTM) Adagene|ADAG - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth adagene.com|ADAG - Earnings growth in current year|Earnings growth forecast for next year Adagene
Initial company analysis:Adagene Corp ADAG
The development of targeted immunotherapy via Adagene (ADAG) AI hubs requires significant capital expenditure, making the business valuation relative to operating profit (EBITDA) critical for assessing efficiency. This indicator accounts for net debt and taxes, allowing investors to identify a fundamental floor or the risk of a value trap by analyzing the company's valuation trend via EV/EBITDA.
Competitors of Adagene
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|EV/EBITDA Multiple Precigen Inc|EV/EBITDA Multiple PHAR|Nektar Corp (NKTR) - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple UPB (Upstream Bio Inc)|zenasbio.com (ZBIO) - Company Value to EBITDA|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GOSS (Gossamer Bio Inc) - Enterprise Value to Operating Income Before Depreciation|KALV: EV/EBITDA Multiple|Company Value to EBITDA Septerna Pharma (SEPN)|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|EV/EBITDA Multiple savarapharma.com|EV/EBITDA Multiple RIGL|AnaptysBio Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATXS (Astria Pharma)|EV/EBITDA Multiple enGene Corp ENGN|RAPT Therapeutics - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Aerovate Therapeutics Inc (JBIO)|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio KYTX (Kyverna Therapeutics Inc.)|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|CABA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple VTYX|EV/EBITDA Multiple theratech.com (THTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|Business Value to Operating Income Before Depreciation ELDN|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Climb Bio, Inc (CLYM) - Enterprise Value to EBITDA Ratio|ZURA: EV/EBITDA Multiple|atyrpharma.com (ATYR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio IMA|STTK: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple EQ|Total Company Value to Operating Income Before Depreciation Ratio connectbiopharm.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA - Enterprise Value to EBITDA Ratio|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|ACET (adicetbio.com) - Enterprise Value to EBITDA Ratio|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to Operating Income Before Depreciation BRNS (barinthusbio.com)|EV/EBITDA Multiple KZR|SABS - Company Value to EBITDA|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - EV/EBITDA Multiple|GOVX (geovax.com) - Enterprise Value to Operating Income Before Depreciation|EDSA: EV/EBITDA Multiple|iBio Inc (IBIO) - EV/EBITDA Multiple|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|XTLB - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple BOLT|HCWB - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM: Enterprise Value to Operating Income Before Depreciation|Aditxt Corp - EV/EBITDA Multiple|Company Value to EBITDA GRI Bio Corporation|XRTX: EV/EBITDA Multiple|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|EV/EBITDA Multiple SCNI|EV/EBITDA Multiple calcimedica.com (CALI)|EV/EBITDA Multiple AFMD (Affimed N.V.)|Enterprise Value to EBITDA Multiple Allakos Inc|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IGMS|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
